EDAP Appoints Frank Van Hyfte as Vice President of Global Sales and Marketing

• Seasoned medical technology sales and marketing professional brings more than 25 years of experience to the EDAP team
• Joins EDAP from Exact Imaging to lead the recently announced global distribution agreement between the two companies

LYON, France, May 28, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announced today the appointment of Frank Van Hyfte as Vice President of Global Sales and Marketing. Mr. Van Hyfte joins EDAP from Exact Imaging, where he most recently served as Executive Vice-President of Worldwide Sales and Marketing. On May 12, 2020, EDAP announced that the Company had entered into an exclusive worldwide distribution agreement with Exact Imaging to integrate Exact’s ExactVu and other micro ultrasound diagnostic products in EDAP’s offering in the management of prostate cancer as a stand-alone range or in combination with its Focal One high intensity focused ultrasound (HIFU) treatment technology.

Marc Oczachowski, Chairman and Chief Executive Officer of EDAP, commented: “Frank is a highly accomplished sales leader with a proven track record of success, and I could not be happier that he has joined the EDAP team. Frank is a great addition to our worldwide sales team with his deep specialized experience in prostate cancer and in particular his 16 years at Intuitive Surgical, where he contributed to building the Da Vinci robot into the current success that we know today, as well as his recent experience in launching the Exact Imaging technology. We believe Frank’s experience will drive accelerating adoption of our technologies, allowing us to maximize the potential of the Exact Imaging agreement, and helping us further penetrate existing accounts while accelerating growth in our sales pipeline.”

“I am pleased to have this opportunity to lead the EDAP-Exact Imaging sales effort and I am eager to hit the ground running with a new offering that combines Exact Imaging’s micro ultrasound diagnostic technology with EDAP’s Focal One HIFU-based treatment device,” stated Mr. Van Hyfte. “Together, these technologies represent the first true end-to-end solution allowing urologists worldwide to employ the latest advancements in prostate cancer management, from screening and diagnosis through treatment. I look forward to making this highly differentiated solution available to treating physicians around the world.”